Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony D Ho

Showing results (311-320 of 346) with videos related to

Pageof 35
Sort By:
Leukemia|August 27, 2024
Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 studyPatrick Derigs, Maria-Luisa Schubert, Peter Dreger, et al.
Nature Cell Biology|March 21, 2017
Human haematopoietic stem cell lineage commitment is a continuous processLars Velten, Simon F Haas, Simon Raffel, et al.
Cancer Investigation|September 20, 2006
Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphomaUlrich J M Mey, Katjana S Orlopp, Dimitri Flieger, et al.
Blood|April 23, 2013
Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6Mathias Witzens-Harig, Dirk Hose, Simone Jünger, et al.
Cancer Research|September 4, 2012
GF-15, a novel inhibitor of centrosomal clustering, suppresses tumor cell growth in vitro and in vivoMarc S Raab, Iris Breitkreutz, Simon Anderhub, et al.
British Journal of Haematology|September 17, 2013
Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemiaAlexander Jethwa, Jennifer Hüllein, Tatjana Stolz, et al.
Nature Communications|October 3, 2018
Cell-specific proteome analyses of human bone marrow reveal molecular features of age-dependent functional declineMarco L Hennrich, Natalie Romanov, Patrick Horn, et al.
Blood|June 20, 2020
Quantitative proteomics reveals specific metabolic features of acute myeloid leukemia stem cellsSimon Raffel, Daniel Klimmeck, Mattia Falcone, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2015
Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITDAnthony D Ho, Johannes Schetelig, Tilmann Bochtler, et al.
Cytotherapy|May 27, 2014
Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applicationsPatrick Wuchter, Karen Bieback, Hubert Schrezenmeier, et al.
Pageof 35

Showing results (311-320 of 346) with videos related to

Sort By:
Pageof 35
Leukemia|August 27, 2024
Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 studyPatrick Derigs, Maria-Luisa Schubert, Peter Dreger, et al.
Nature Cell Biology|March 21, 2017
Human haematopoietic stem cell lineage commitment is a continuous processLars Velten, Simon F Haas, Simon Raffel, et al.
Cancer Investigation|September 20, 2006
Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphomaUlrich J M Mey, Katjana S Orlopp, Dimitri Flieger, et al.
Blood|April 23, 2013
Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6Mathias Witzens-Harig, Dirk Hose, Simone Jünger, et al.
Cancer Research|September 4, 2012
GF-15, a novel inhibitor of centrosomal clustering, suppresses tumor cell growth in vitro and in vivoMarc S Raab, Iris Breitkreutz, Simon Anderhub, et al.
British Journal of Haematology|September 17, 2013
Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemiaAlexander Jethwa, Jennifer Hüllein, Tatjana Stolz, et al.
Nature Communications|October 3, 2018
Cell-specific proteome analyses of human bone marrow reveal molecular features of age-dependent functional declineMarco L Hennrich, Natalie Romanov, Patrick Horn, et al.
Blood|June 20, 2020
Quantitative proteomics reveals specific metabolic features of acute myeloid leukemia stem cellsSimon Raffel, Daniel Klimmeck, Mattia Falcone, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2015
Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITDAnthony D Ho, Johannes Schetelig, Tilmann Bochtler, et al.
Cytotherapy|May 27, 2014
Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applicationsPatrick Wuchter, Karen Bieback, Hubert Schrezenmeier, et al.
Pageof 35